Akathisia after chronic usage of synthetic cathinones
A case study
Bibliographic Data
| ID | 15529484 |
|---|---|
| Authors | Niels Albert (University of Antwerp, corresponding author), Kirsten Catthoor (0000-0002-8738-8364, Ziekenhuisnetwerk Antwerpen Stuivenberg), Manuel Morrens (0000-0003-4559-3666, University of Antwerp) |
| Year | 2022 |
| Volume | 13 |
| Pages | 1046486-1046486 |
| Publication date | 2022-12-23 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2022.1046486 |
| PMID | 36620653 |
| OpenAlex | W4312175626 |
| Language | EN |
| References cited | 1 |
The current case suggests that besides cocaine, amphetamines and methamphetamines, synthetic cathinones can also increase the risk for development of extrapyramidal symptoms such as akathisia. Especially a-PVP-analogs as used by the current patient and Pyrovalerone-analogs such as Methylenedioxypyrovalerone (MDPV) are very powerful dopamine reuptake-inhibitors which might lead to strong locomotor activation. Up to this day it remains very difficult to establish a guideline concerning the treatment of intoxication with synthetic cathinones or dependence thereof
Akathisia · Antipsychotic · Psychiatry · Schizophrenia (object-oriented programming · Synthetic cannabinoids · Drug-Induced Adverse Reactions · Forensic Toxicology and Drug Analysis · Medicine · Psychedelics and Drug Studies · Internal Medicine
| Highly cited | No |
|---|